A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

Status:
RECRUITING

Trial end date:
2025-04-01

Target enrollment:

Participant gender:

Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-227 in healthy subjects.

PHASE1

Addpharma Inc.